Skip to main content
. 2022 Jul 4;14(13):3276. doi: 10.3390/cancers14133276

Figure 5.

Figure 5

Establishment of nomogram and immune infiltration analysis. (A) Univariable analysis and multivariable analysis of clinical characteristics and IRSHG. *** p < 0.001 (B) Nomogram for predicting the probability of 1-, 3-, and 5-year overall survival in HP+ GC patients. (C) Heatmap illustrating the estimated scores of immune signatures calculated by ssGSEA and ESTIMATE algorism in the high- and low-risk groups. Previously reported transcriptome-based molecular classifications for GC were presented on the top of heatmap simultaneously. (D) Correlation of 24 immune cells in the high-risk group and the low-risk group, respectively.